Press Release: April 24th, 2019
Edanz Group Japan Inc. (“edanz”: Fukuoka, Japan; URLs: https://www.edanzwriting.com & https://www.edanzediting.com), the global leader in high-quality scientific and medical research support, has joined M3, Inc. the global leader in healthcare information services, (TSE 2413: Tokyo, Japan; URL: https://corporate.m3.com/; CEO: Itaru Tanimura; “M3” below).
M3 operates m3.com, a specialized web portal for medical professionals that delivers healthcare-related information to over 270,000 physician members in Japan, offering marketing and clinical trial services. M3 operates in 10 of the countries with the largest healthcare systems, including the US, UK, France, China, Korea, and India, with over 5 million physicians as members across its global platforms.
As part of the M3 group, Edanz is focused on delivering high-quality scientific and medical manuscript publication support services and specialized research support services. Edanz provides medical writing, gap and situational analyses, strategic publication plans, protocol design, and educational tools and solutions to pharmaceutical and healthcare companies, and individual physicians and biomedical researchers.
Edanz will operate independently within the M3 group, continuing to support all research areas, with its core operations in Japan and China, and a global team of high-quality scientific and editorial experts. The demand for evidence generation has been expanding rapidly, and Edanz expects to scale its support services, and to seek collaboration with global academic publishers and learned societies to develop services to support 5 million M3 platform members, including 2.5 million members in China.
Chief Executive Officer
For media inquiries:
Sam Kinred, Marketing Manager, Edanz
skinred “at” edanzgroup.com